Cargando…
Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging
Males, who are bigger and stronger than females, die younger in most species from flies to mammals including humans. Cellular mass growth is driven in part by mTOR (Target of Rapamycin). When developmental growth is completed, then, instead of growth, mTOR drives aging, manifested by increased cellu...
Autores principales: | Leontieva, Olga V., Paszkiewicz, Geraldine M., Blagosklonny, Mikhail V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615157/ https://www.ncbi.nlm.nih.gov/pubmed/23443503 |
Ejemplares similares
-
Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet
por: Leontieva, Olga V, et al.
Publicado: (2014) -
Gerosuppression by pan-mTOR inhibitors
por: Leontieva, Olga V., et al.
Publicado: (2016) -
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
por: Querfurth, Henry, et al.
Publicado: (2021) -
Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet
por: Leontieva, O V, et al.
Publicado: (2013) -
DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence
por: Leontieva, Olga V., et al.
Publicado: (2010)